Gastroenterology
Volume 137, Issue 4 , Pages 1207-1210 , October 2009

The Power of Placebo in Pediatric Functional Gastrointestinal Disease

  • Marc A. Benninga

      Affiliations

    • Department of Pediatric Gastroenterology, Emma Children's Hospital/Academic Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationReprint requests Address requests for reprints to: Marc A. Benninga, MD, PhD, Emma Children's Hospital/Academic Medical Centre, Department of Pediatric Gastroenterology and Nutrition, Room G8-261, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    • ,
  • Emeran A. Mayer

      Affiliations

    • Center for Neurobiology of Stress, Department of Medicine, Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, California

References 

  1. Apley J, Naish N. Recurrent abdominal pains: a field survey of 1,000 school children. Arch Dis Child. 1958;33:165–170
  2. Rasquin A, Di Lorenzo C, Forbes D, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2006;130:1527–1537
  3. Baber KF, Anderson J, Puzanovova M, et al. Rome II versus Rome III classification of functional gastrointestinal disorders in pediatric chronic abdominal pain. J Pediatr Gastroenterol Nutr. 2008;47:299–302
  4. Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in western countries: a systematic review. Am J Gastroenterol. 2005;100:1868–1875
  5. Perquin CW, Hazebroek-Kampschreur AA, Hunfeld JA, et al. Pain in children and adolescents: a common experience. Pain. 2000;87:51–58
  6. Gieteling MJ, Bierma-Zeinstra SM, Passchier J, et al. Prognosis of chronic or recurrent abdominal pain in children. J Pediatr Gastroenterol Nutr. 2008;47:316–319
  7. Youssef NN, Murphy TG, Langseder AL, et al. Quality of life for children with functional abdominal pain: a comparison study of patients' and parents' perceptions. Pediatrics. 2006;117:54–59
  8. Saps M, Youssef N, Miranda A, et al. Multicenter, randomized placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology. 2009;137:1261–1269
  9. Thompson WG. The Placebo Effect in Health: Combining Science and Compassionate Care. New York: Prometheus; 2005;
  10. Krogsbøll LT, Hróbjartsson A, Gøtzsche PC. Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC Med Res Methodol. 2009;9:1
  11. Kaptchuk TJ, Kelley JM, Conboy LA, et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ. 2008;336:999–1003
  12. Patel SM, Stason WB, Legedza A, et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil. 2005;17:332–340
  13. Lieberman MD, Jarcho JM, Berman S, et al. The neural correlates of placebo effects: a disruption account. Neuroimaging. 2004;22:447–455
  14. Zubieta JK, Stohler CS. Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci. 2009;1156:198–210
  15. Committee for proprietary Medical products (CPMP), CPMP/EWP/785/97. Points to consider on the evaluation of medicinal products for the treatment of IBS. 785/97 ed.. European Agency for the evaluation of Medicinal Products; 2003;
  16. Tsao JCI, Lu Q, Myers CD, et al. Parent and child anxiety sensitivity: relationship to children's experimental pain responsivity. J Pain. 2006;7:319–326
  17. Walker LS, Guite JW, Duke M, et al. Recurrent abdominal pain: a potential precursor of irritable bowel syndrome in adolescents and young adults. J Pediatr. 1998;132:1010–1015
  18. Lindley KJ, Glaser D, Milla PJ. Consumerism in healthcare can be detrimental to child health: lessons from children with functional abdominal pain. Arch Dis Child. 2005;90:335–337
  19. Food and Drug Administration/Center for Drug Evaluation and Research Official Website. http://www.fda.gov/cder/drug/antidepressants/default.htmAccessed February 3, 2005
  20. Bahar RJ, Collins BS, Steinmetz B, Ament ME. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr. 2008;152:685–689
  21. Berger MY, Gieteling MJ, Benninga MA. Chronic abdominal pain in children. BMJ. 2007;334:997–1002
  22. Walker LS, Williams SE, Smith CA, et al. Parent attention versus distraction: impact on symptom complaints by children with and without chronic functional abdominal pain. Pain. 2006;122:43–52
  23. van Tilburg MA, Chitkara DK, Palsson OS, et al. Parental worries and beliefs about abdominal pain. J Pediatr Gastroenterol Nutr. 2009;48:311–317
  24. Walker LS, Garber J, Van Slyke DA, Greene JW. Longterm health outcomes in patients with recurrent abdominal pain. J Pediatr Psychol. 1995;20:233–245
  25. Pace F, Zuin G, Di GS, et al. Family history of irritable bowel syndrome is the major determinant of persistent abdominal complaints in young adults with a history of pediatric recurrent abdominal pain. World J Gastroenterol. 2006;12:3874–3877
  26. Campo JV, Di LC, Chiappetta L, et al. Adult outcomes of pediatric recurrent abdominal pain: do they just grow out of it?. Pediatrics. 2001;108:E1
  27. Huertas-Ceballos A, Macarthur C, Logan S. Pharmacological interventions for recurrent abdominal pain (RAP) in childhood. Cochrane Database of Systematic Reviews [Online]. 2002;(1):CD003017
  28. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology. 2002;122:1140–1156
  29. Campo JV, Bridge J, Ehmann M, et al. Recurrent abdominal pain, anxiety, and depression in primary care. Pediatrics. 2004;113:817–824
  30. Mayer EA. Clinical practice (Irritable bowel syndrome). N Engl J Med. 2008;358:1692–1699
  31. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2005;3:CD005454
  32. Jackson JL, O'Malley PG, Tomkins G, et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med. 2000;108:65–72
  33. Lesbros-Pantoflickova D, Michetti P, Fried M, et al. Meta-analysis: the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2004;20:1253–1269
  34. Brandt LJ, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97:S7–S26
  35. Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125:19–31
  36. Clouse RE, Lustman PJ. Use of psychopharmacological agents for functional gastrointestinal disorders. Gut. 2005;54:1332–1341
  37. Sanders MR, Shepherd RW, Cleghorn G, et al. The treatment of recurrent abdominal pain in children: a controlled comparison of cognitive-behavioral family intervention and standard pediatric care. J Consult Clin Psychol. 1994;62:306–314
  38. Robins PM, Smith SM, Glutting JJ, et al. A randomized controlled trial of a cognitive-behavioral family intervention for pediatric recurrent abdominal pain. J Pediatr Psychol. 2005;30:397–408
  39. Vlieger AM, Menko-Frankenhuis C, Wolfkamp SC, et al. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial. Gastroenterology. 2007;133:1430–1436
  40. Kupers R, Faymonville ME, Laureys S. The cognitive modulation of pain: hypnosis- and placebo-induced analgesia. Prog Brain Res. 2005;150:251–269

 Conflicts of interest The authors disclose no conflicts.

PII: S0016-5085(09)01488-7

doi: 10.1053/j.gastro.2009.08.023

Gastroenterology
Volume 137, Issue 4 , Pages 1207-1210 , October 2009

Article Tools